Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Old wine in new bottles: Drug repurposing in oncology
Michał Antoszczak, Anna Markowska, Janina Markowska, et al.
European Journal of Pharmacology (2019) Vol. 866, pp. 172784-172784
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Molecules from nature: Reconciling biodiversity conservation and global healthcare imperatives for sustainable use of medicinal plants and fungi
Melanie‐Jayne R. Howes, Cassandra L. Quave, Jérôme Collemare, et al.
Plants People Planet (2020) Vol. 2, Iss. 5, pp. 463-481
Open Access | Times Cited: 149
Ivermectin: An Anthelmintic, an Insecticide, and Much More
Richard J. Martin, Alan P. Robertson, Shivani Choudhary
Trends in Parasitology (2020) Vol. 37, Iss. 1, pp. 48-64
Open Access | Times Cited: 141
Pleiotropic effects of statins: A focus on cancer
Mazaher Ahmadi, Shayan Amiri, Stevan Pecic, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 12, pp. 165968-165968
Open Access | Times Cited: 125
Ivermectin, a potential anticancer drug derived from an antiparasitic drug
Mingyang Tang, Xiao Hu, Yi Wang, et al.
Pharmacological Research (2020) Vol. 163, pp. 105207-105207
Open Access | Times Cited: 84
Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinić, Thomas Efferth, Alfonso T. García‐Sosa, et al.
Drug Resistance Updates (2020) Vol. 52, pp. 100713-100713
Open Access | Times Cited: 79
Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
Rafaela Rodrigues, Diana Duarte, Nuno Vale
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4280-4280
Open Access | Times Cited: 44
Biguanides: Species with versatile therapeutic applications
Deepika Kathuria, Akshay D. Raul, Pravin J. Wanjari, et al.
European Journal of Medicinal Chemistry (2021) Vol. 219, pp. 113378-113378
Closed Access | Times Cited: 49
Honeybee Venom Synergistically Enhances the Cytotoxic Effect of CNS Drugs in HT-29 Colon and MCF-7 Breast Cancer Cell Lines
Diana Duarte, Soraia I. Falcão, Iouraouine El Mehdi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 511-511
Open Access | Times Cited: 30
Antiparasitic activity of ivermectin: Four decades of research into a “wonder drug”
Michał Sulik, Michał Antoszczak, Adam Huczyński, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115838-115838
Open Access | Times Cited: 20
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
Krishnaprasad Baby, Swastika Maity, Chetan Hasmukh Mehta, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Drug Repositioning for Alzheimer’s Disease: Finding Hidden Clues in Old Drugs
Masafumi Ihara, Satoshi Saitô
Journal of Alzheimer s Disease (2020) Vol. 74, Iss. 4, pp. 1013-1028
Closed Access | Times Cited: 40
Biguanides drugs: Past success stories and promising future for drug discovery
Oleksandr Grytsai, Iuliia Myrgorodska, Stéphane Rocchi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113726-113726
Open Access | Times Cited: 33
Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells
Diana Duarte, Alexandra Rêma, Irina Amorim, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 190-190
Open Access | Times Cited: 23
Phages in the Fight Against COVID-19?
Andrzej Górski, Ryszard Międzybrodzki, Maciej Żaczek, et al.
Future Microbiology (2020) Vol. 15, Iss. 12, pp. 1095-1100
Open Access | Times Cited: 34
Repurposing of Drug Candidates for Treatment of Skin Cancer
Hernán Cortés, Octavio D. Reyes‐Hernández, Sergio Alcalá-Alcalá, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 28
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action
Diana Duarte, Mariana Nunes, Sara Ricardo, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1490-1490
Open Access | Times Cited: 21
Antidepressant Drug Sertraline against Human Cancer Cells
Diana Duarte, Nuno Vale
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1513-1513
Open Access | Times Cited: 21
Nanomaterial-Based Drug Delivery Systems: A New Weapon for Cancer Immunotherapy
Zhengting Jiang, Wenjie Zhang, Jie Zhang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 4677-4696
Open Access | Times Cited: 19
Sertaconazole nitrate targets IDO1 and regulates the MAPK signaling pathway to induce autophagy and apoptosis in CRC cells
Yiren Yang, Yue Jin, Linzhou Yin, et al.
European Journal of Pharmacology (2023) Vol. 942, pp. 175515-175515
Closed Access | Times Cited: 10
Improvement of the In Vitro Cytotoxic Effect on HT-29 Colon Cancer Cells by Combining 5-Fluorouacil and Fluphenazine with Green, Red or Brown Propolis
Soraia I. Falcão, Diana Duarte, Moustapha Diallo, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3393-3393
Open Access | Times Cited: 10
Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer
Maritza P. Garrido, Allison N. Fredes, Lorena Lobos‐González, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 77-77
Open Access | Times Cited: 25
Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women
Anna Markowska, Michał Antoszczak, Janina Markowska, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 422-422
Open Access | Times Cited: 24
Modulating undruggable targets to overcome cancer therapy resistance
Catherine Passirani, Anne Vessières, Giuseppe La Regina, et al.
Drug Resistance Updates (2021) Vol. 60, pp. 100788-100788
Open Access | Times Cited: 21
Sustained In Vitro and In Vivo Delivery of Metformin from Plant Pollen-Derived Composite Microcapsules
Noha M. Meligi, Amro K. F. Dyab, Vesselin N. Paunov
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1048-1048
Open Access | Times Cited: 20
Drug repositioning for cancer in the era of AI, big omics, and real-world data
Robert Wieder, Nabil R. Adam
Critical Reviews in Oncology/Hematology (2022) Vol. 175, pp. 103730-103730
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top